Concepedia

Publication | Closed Access

<scp>CYT</scp>003, a <scp>TLR</scp>9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b study

DOI

67

Citations

30

References

2015

Year

Thomas B. Casale, Jeremy Cole, Ekkehard Beck, Claus Vogelmeier, Jörg Willers, Cheryl Lassen, Anya Hammann‐Haenni, L. Trokan, Philippe Saudan, M.E. Wechsler
Allergy

Abstract

Toll-like receptor-9 agonism with CYT003 showed no additional benefit in patients with insufficiently controlled moderate-to-severe allergic asthma receiving standard inhaled glucocorticosteroid therapy with or without LABAs.

References

YearCitations

Page 1